Intrastriatal injection of hypoxanthine alters striatal ectonucleotidase activities: A time-dependent effect

Brain Research

Volumn 1239, Issue , 2008, Pages 198-206

  Bavaresco, Caren S ^a   Chiarani, Fabria ^a   Kolling, Janaina ^a   Ramos, Denise B ^a   Cognato, Giana P ^a   Bonan, Carla D ^b   Bogo, Maurício R ^b   Sarkis, João J F ^a   Netto, Carlos A ^a   Wyse, Angela T S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Ectonucleotidase; Intrastriatal hypoxanthine administration; Lesch Nyhan disease; NTPDase; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; ECTO 5' NUCLEOTIDASE; HYPOXANTHINE; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 2; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 3; NUCLEOTIDASE; NUCLEOTIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; ENZYME INHIBITION; HYDROLYSIS; LESCH NYHAN SYNDROME; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TIME;

5'-NUCLEOTIDASE; ADENOSINE TRIPHOSPHATASES; ANIMALS; ANTIGENS, CD; APYRASE; ASCORBIC ACID; CENTRAL NERVOUS SYSTEM AGENTS; CORPUS STRIATUM; HYDROLYSIS; HYPOXANTHINE; MALE; NUCLEOTIDES; PYROPHOSPHATASES; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS; VITAMIN E; VITAMINS;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 53949096094     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.08.015     Document Type: Article

References (62)

1. +-ATPase activity in rat striatum by metabolites accumulated in Lesch Nyhan disease. Int. J. Devl. Neurosci. 22 (2004) 11-17
2. +-ATPase activity and some parameters of oxidative stress in rat striatum. Brain Res. 1041 (2005) 198-204
3. +-ATPase activity and induces oxidative stress in the rats. Metab. Brain Dis. 22 (2007) 1-11
4. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-die binding. Anal. Biochem. 72 (1976) 248-254
5. Beckman J.S., Liu T.H., Hogan E.L., Freeman B.A., and Hsu C.Y. Oxygen free radicals and xanthine oxidase in cerebral ischemic injury in the rat. Soc. Neurosci. Abstr. 13 (1987) 1498
6. Bertelli M., Cecchin S., Lapucci C., Jacomelli G., Jinnah H.A., Pandolfo M., and Micheli V. Study of the adenosinergic system in the brain of HPRT knockout mouse (Lesch-Nyhan disease). Clin. Chim. Acta 373 (2006) 104-107
7. Berti S.L., Bonan C.D., and da Silva F.L. Phenylalanine and phenylpyruvate inhibit ATP diphosphohydrolase from rat brain cortex. Int. J. Dev. Neurosci. 19 (2001) 649-653
8. Braun N., Lenz C., Gillardon F., Zimmermann M., and Zimmermann H. Focal cerebral ischemia enhances glial expression of 5-nucleotidase. Brain Res. 766 (1997) 213-226
9. Brosh S., Boer P., Sperling O., and Zoref-Shani E. Elevated UTP and CTP content in cultured neurons from HPRT-deficient transgenic mice. J. Mol. Neurosci. 14 (2000) 87-91
10. +-stimulated ATPase activity. Anal. Biochem. 157 (1986) 375-380
11. Dasheiff R.M. Benzodiazepinic treatment for Lesch-Nyhan syndrome?. Dev. Med. Child Neurol. 22 (1980) 101-102
12. Delwing D., Goncalves M.C., Sarkis J.J., and Wyse A.T. L-NAME administration prevents the inhibition of nucleotide hydrolysis by rat blood serum subjected to hyperargininemia. Amino Acids 29 (2005) 267-272
13. Delwing D., Delwing D., Sarkis J.J., and Wyse A.T. Proline induces alterations on nucleotide hydrolysis in synaptosomes from cerebral cortex of rats. Brain Res. 1149 (2007) 210-215
14. Esterbauer H., and Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186 (1990) 407-421
15. Ferrari D., Chiozzi P., Falzoni S., Dal Susino M., Collo G., Buell G., and Di Virgilio F. ATP-mediated cytotoxicity in microglial cells. Neuropharmacology 36 (1997) 1295-1301
16. Floyd R.A. Antioxidants, oxidative stress and degenerative neurological disorders. Proc. Soc. Exp. Biol. Med. 222 (1999) 236-245
17. Halliwell B. Free radicals, proteins and DNA: oxidative damage versus redox regulation. Biochem. Soc. Trans. 24 (1996) 1023-1027
18. Harkness R.A., McCreanor G.M., and Watts R.W. Lesch-Nyhan syndrome and its pathogenesis: purine concentrations in plasma and in urine with metabolite profiles in CSF. J. Inher. Metab. Dis. 11 (1988) 239-252
19. Henderson J.F. Possible functions of hypoxanthine-guanine phosphoribosyltransferase and their relation to the biochemical pathology of the Lesch-Nyhan syndrome. Fed. Proc. 27 (1968) 1075-1077
20. Heymann D., Reddington M., and Kreutzberg G.W. Subcellular localization of 5′-nucleotidase in rat brain. J. Neurochem. 43 (1984) 971-978
21. Jinnah H.A., and Friedmann T. Lesch Nyhan disease and it variants. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease. 8th Edition (2001), McGraw-Hill, New York 2537-2569
22. Jinnah H.A., and Gage F.H. Animal models of Lesch-Nyhan syndrome. Brain Res. Bull. 25 (1990) 467-475
23. Jinnah H.A., Page T., and Friedmann T. Brain purines in a genetic mouse model of Lesch-Nyhan disease. J. Neurochem. 60 (1993) 2036-2045
24. Kisch S.J., Fox I.H., Kapur B.M., Lloyd K.G., and Hornykiewicz O. Brain benzodiazepine receptor binding and purine concentration in Lesch-Nyhan. Brain Res. 336 (1985) 117-123
25. Komoszynski M., and Wojtczak A. Apyrases (ATP diphosphohydrolases, EC 3.6.1.5): function and relationship to ATPases. Biochim. Biophys. Acta 1310 (1996) 233-241
26. Krishna S.M., Katoor J., and Balaram P. Down regulation of adhesion protein E-cadherin in Epstein-Barr virus infected nasopharyngeal carcinomas. Cancer Biomark 1 (2006) 271-277
27. Lorenz V., Pinto C.S., and Seifert R. Complex changes in ecto-nucleoside 5′-triphosphate diphosphohydrolase expression in hypoxanthine phosphoribosyl transferase deficiency. Neurosci. Lett. 420 (2007) 6-11
28. Ma M.H.Y., Stacey N.C., and Connolly G.P. Hypoxanthine impairs morphogenesis and enhances proliferation of a neuroblastoma model of Lesch Nyhan syndrome. J. Neurosci. Res. 63 (2001) 500-508
29. Martinelli A., and Tuccinardi T. Molecular modeling of adenosine receptors: new results and trends. Med. Res. Rev. 28 (2008) 247-277
30. Matthews W.S., Solan A., Barabas G., and Robey K. Cognitive functioning in Lesch-Nyhan syndrome: a 4-year follow-up study. Dev. Med. Child Neurol. 41 (1999) 260-262
31. Matute C., Alberdi E., Domercq M., Sanchez-Gomez M.V., Perez-Samartin A., Rodriguez-Antiguedad A., and Perez-Cerda F. Excitotoxic damage to white matter. J. Anat. 210 (2007) 693-702
32. Mizuno T. Long-term follow-up of ten patients with Lesch-Nyhan syndrome. Neuropediatrics 17 (1986) 158-161
33. Nagy A.K., and Delgado-Escueta A.V. Rapid preparation of synaptosomes from mammalian brain using a non toxic isoosmotic gradient (Percoll). J. Neurochem. 43 (1984) 1114-1123
34. Neychev V.K., and Mitev V.I. The biochemical basis of the neurobehavioral abnormalities in the Lesch-Nyhan syndrome: a hypothesis. Med. Hypotheses 63 (2004) 131-134
35. Nyhan W.L., Oliver W.J., and Lesch M. A familial disorder or uric acid metabolism and central nervous system function II. J. Pediatr. 67 (1965) 439-444
36. Oliveira P.J., Rolo A.P., Palmeira C.M., and Moreno A.J. Carvedilol reduces mitochondrial damage induced by hypoxanthine/xanthine oxidase: relevance to hypoxia/reoxygenation injury. Cardiovasc. Toxicol. 1 (2001) 205-213
37. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, London
38. Pesi R., Micheli V., Jacomelli G., Peruzzi L., Camici M., Garcia-Gil M., Allegrini S., and Tozzi M.G. Cytosolic 5′-nucleotidase hyperactivity in erythrocytes of Lesch-Nyhan syndrome patients. Neuroreport 9 (2000) 1827-1831
39. Pinto C.S., Jinnah H.A., Shirley T.L., Nyhan W.L., and Seifert R. Altered membrane NTPase activity in Lesch-Nyhan disease fibroblasts: comparison with HPRT knockout mice and HPRT-deficient cell lines. J. Neurochem. 93 (2005) 1579-1586
40. Prior C., Torres R.J., and Puig J.G. Hypoxanthine effect on equilibrative and concentrative adenosine transport in human lymphocytes: implications in the pathogenesis of Lesch-Nyhan syndrome. Nucleosides Nucleotides Nucleic Acids 25 (2006) 1065-1069
41. Puig J.G., and Mateos F.A. The biochemical basis of HGPRT deficiency. In: Gresser U. (Ed). Molecular Genetics, Biochemistry and Clinical Aspects of Inherited Disorders of Purine and Pyrimidine Metabolism (1993), Springer-Verlag, New York 12-26
42. Puig J.G., Jimenez M.L., and Mateos F.A. Adenine nucleotide turnover in hypoxanthine-guanine phosphoribosyl-transferase: evidence for an increased contribution of purine biosyntheses de novo. Metabolism 38 (1989) 410-418
43. Rijksen G., Staal G.E.J., Van der Vlist M.J.M., Beerner F.A., Troost J., Gutensohn W., Van Laarhoven J.P.R.M., and De Bruyn C.H.M.M. Partial hypoxanthine-guanine phosphoribosyl transferase deficiency with full expression of the Lesch-Nyhan syndrome. Hum. Gen. 57 (1981) 39-47
44. Ribeiro J.A., Lobo M.G., and Sebastião A.M. Endogenous adenosine modulation of 22Na uptake by rat brain synaptosomes. Neurochem. Res. 28 (2003) 1591-1595
45. Rosenbloom R.M., Henderson J.F., and Caldwell I.C. Inherited disorder of purine metabolism. JAMA 202 (1967) 175-177
46. Schiffmann S.N., and Vanderhaeghen J.J. Age-related loss of mRNA encoding adenosine A2 receptor in the rat striatum. Neurosci. Lett. 158 (1993) 121-124
47. Siegfried G., Amiel C., and Friedlander G. Inhibition of ecto-5′-nucleotidase by nitric oxide donors. Implications in renal epithelial cells. J. Biol. Chem. 271 (1996) 4659-4664
48. Spector R. Hypoxanthine transport through the blood-brain barrier. Neurochem. Res. 12 (1987) 791-796
49. Spector R. Hypoxanthine transport and metabolism in the central nervous system. J. Neurochem. 50 (1988) 969-978
50. Sweetman L., and Nyhan W.L. Detailed comparison of the urinary excretion of purines in a patient with Lesch-Nyhan syndrome and a control subject. Biochem. Med. 4 (1970) 121-134
51. Tinton S.A., Lefebvre V.H., and Cousin O.C. Cytolytic effects and biochemical changes induced by extracellular ATP to isolated hepatocytes. Biochim. Biophys. Acta 1176 (1993) 1-6
52. Torres R.J., DeAntonio I., Prior C., and Puig J.G. Adenosine transport in HPRT deficient lymphocytes from Lesch-Nyhan disease patients. Nucleosides Nucleotides Nucleic Acids 23 (2004) 1193-1196
53. Ushijima I., Katsuragi T., and Furukawa T. Involvement of adenosine receptor activities in aggressive responses produced by clonidine in mice. Psychopharmacology (Berl) 83 (1984) 335-339
54. Vietta M., Frassetto S.S., Battastini A.M., Bello-Klein A., Moreira C., Dias R.D., and Sarkis J.J. Sensitivity of ATPase-ADPase activities from synaptic plasma membranes of rat forebrain to lipid peroxidation in vitro and the protective effect of vitamin E. Neurochem. Res. 21 (1996) 299-304
55. Visser J.E., Bär P.R., and Jinnah H.A. Lesch-Nyhan disease and the basal ganglia. Brain Res. Bull. 32 (2000) 449-475
56. Visser J.E., Smith D.W., Moy S.S., Breese G.R., Friedmann T., Rothstein J.D., and Jinnah H.A. Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. Brain Res. Dev. Brain Res. 133 2 (2002) 127-139
57. Vuaden F.C., de Paula Cognato G., and Bonorino C. Lipopolysaccharide alters nucleotidase activities from lymphocytes and serum of rats. Life Sci. 80 (2007) 1784-1791
58. Wyse A.T., Zugno A.I., Streck E.L., Bogo M.R., de Freitas Sarkis J.J., and Bonan C.D. Inhibition of Na(+), K(+)-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment. Neurochem. Res. 12 (2002) 1685-1689
59. Zimmermann H. Ectonucleotidases in the nervous system. Novartis Found Symp. 276 (2006) 113-128
60. Zimmermann H., Braun N., Kegel B., and Heine P. New insights into molecular structure and function of ectonucleotidases in the nervous system. Neurochem. Int. 32 (1998) 421-425
61. +-ATPase and creatine kinase can be differentially prevented by taurine and vitamins E and C administration in rat striatum in vivo. Biochim. Biophys. Acta 1772 (2007) 563-569
62. Zhu C.B., Steiner J.A., Munn J.L., Daws L.C., Hewlett W.A., and Blakely R.D. Rapid stimulation of presynaptic serotonin transport by a3 adenosine receptors. J. Pharmacol. Exp. Ther. 322 (2007) 332-340